SCHEMBL11895340

SCHEMBL11895340

COC(=O)c1cc(Cl)nc2ccc3nn(-c4cccc(Cl)c4)nc3c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.47
▸ PKM P14618 1/20 0.42
▸ ALDH1A1 P00352 5/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ TP53 P04637 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ PLA2G2A P14555 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11894930 0.92 KDM4E (0.46) KDM4EPKMALDH1A1HSD17B10HPGD
SCHEMBL11894745 0.91 KDM4E (0.55) KDM4EALDH1A1HSD17B10HPGDALOX15
SCHEMBL11894766 0.91 KDM4E (0.45) KDM4EALDH1A1HSD17B10HPGDALOX15
SCHEMBL11895038 0.88 KDM4E (0.42) KDM4EMAPTKMT2AMEN1TP53
SCHEMBL11895125 0.83 POLB (0.54) KDM4EPKMALDH1A1HSD17B10HPGD
SCHEMBL11894876 0.78 PARP1 (0.48) KDM4EPKMALDH1A1HSD17B10HPGD
SCHEMBL11895063 0.77 PARP1 (0.40) KDM4EPKMALDH1A1HSD17B10HPGD
SCHEMBL11895219 0.76 TP53 (0.37) KDM4EALDH1A1HSD17B10HPGDTDP1
SCHEMBL11894576 0.76 MAPT (0.37) KDM4EALDH1A1HSD17B10HPGDTDP1
SCHEMBL11894800 0.74 PLA2G2A (0.44) KDM4EALDH1A1HSD17B10HPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2487175-A1 PHARMACEUTICAL PRODUCT CONTAINING AROMATIC HETEROCYCLIC COMPOUND Kyowa Hakko Kirin Co., Ltd. (JP) 2012-08-15 — — EP disclosed
US-20120196854-A1 PHARMACEUTICAL COMPOSITION COMPRISING AROMATIC HETEROCYCLIC COMPOUND KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-08-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196854-A1 PHARMACEUTICAL COMPOSITION COMPRISING AROMATIC HETEROCYCLIC COMPOUND CYP2C18, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP2B6 KDM4E 2321/4885PKM 2284/4885ALDH1A1 2046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback